Aug 19, 2019
Last Posted: Aug 16, 2019
- Rates of Actionable Genetic Findings in Individuals with Colorectal Cancer or Polyps Ascertained from a Community Medical Setting
AS Gordon et al, AJHG, AUgust 15, 2019 - Role of liquid biopsies in colorectal cancer.
Wills Beatriz et al. Current problems in cancer 2018 42(6) 593-600 - Survival of familial adenomatous polyposis coexistence colorectal cancer in Iran.
Mirinezhad Seyed Kazem et al. Journal of cancer research and therapeutics 15(1) 87-91 - The Role of Target Therapy in the Treatment of Gastrointestinal Noncolorectal Cancers: Clinical Impact and Cost Consideration.
Berretta Massimiliano et al. Current cancer drug targets 2018 18(5) 430-441 - Benefits, harms and cost-effectiveness of cancer screening in Australia: an overview of modelling estimates.
Lew Jie-Bin et al. Public health research & practice 2019 Jul 29(2) - Clinical exome sequencing vs. usual care for hereditary colorectal cancer diagnosis: A pilot comparative effectiveness study.
Niu Xin et al. Contemporary clinical trials 2019 Aug 105820 - Identification and Clinical Validation of a Novel 4 Gene-Signature with Prognostic Utility in Colorectal Cancer.
Ahluwalia Pankaj et al. International journal of molecular sciences 2019 Aug 20(15) - A Hallmark-Based Six-Gene Expression Signature to Assess Colorectal Cancer and Its Recurrence Risk.
Lu Huiqi et al. Genetic testing and molecular biomarkers 2019 Aug 23(8) 557-564 - [Hereditary colon cancer in Lynch syndrome/HNPCC syndrome in Germany].
Büttner R et al. Der Pathologe 2019 Aug - Colorectal cancer: pharmacogenetics support for the correct drug prescription.
Olivera Gladys et al. Pharmacogenomics 2019 Aug
.png)
No hay comentarios:
Publicar un comentario